Intra-arterial versus standard intravenous administration of lutetium-177-DOTA-octreotate in patients with NET liver metastases: study protocol for a multicenter, randomized controlled trial (LUTIA trial)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intra-arterial versus standard intravenous administration of lutetium-177-DOTA-octreotate in patients with NET liver metastases: study protocol for a multicenter, randomized controlled trial (LUTIA trial)
Authors
Keywords
-
Journal
Trials
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-05
DOI
10.1186/s13063-019-3888-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity
- (2019) A. J. A. T. Braat et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Safety and Efficacy of Combined Peptide Receptor Radionuclide Therapy and Liver Selective Internal Radiation Therapy in a Patient With Metastatic Neuroendocrine Tumor
- (2019) Marco Maccauro et al. CLINICAL NUCLEAR MEDICINE
- Yttrium-90 radioembolization for unresectable metastatic neuroendocrine liver tumor: A systematic review
- (2018) Zhongzhi Jia et al. EUROPEAN JOURNAL OF RADIOLOGY
- 1316PImpact of liver tumor burden on therapeutic effect of 177Lu-dotatate treatment in NETTER-1 study
- (2018) J Strosberg et al. ANNALS OF ONCOLOGY
- Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model
- (2017) Duc Do Minh et al. EUROPEAN RADIOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios
- (2017) Dennis Kupitz et al. PLoS One
- Liver transarterial embolizations in metastatic neuroendocrine tumors
- (2017) Louis de Mestier et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Quantitative Imaging for Targeted Radionuclide Therapy Dosimetry - Technical Review
- (2017) Tiantian Li et al. Theranostics
- Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival
- (2016) James X. Chen et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0,Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver Metastases
- (2016) G. S. Limouris et al. CLINICAL NUCLEAR MEDICINE
- ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
- (2016) M. Pavel et al. NEUROENDOCRINOLOGY
- Specific efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced neuroendocrine tumours of the small intestine
- (2015) Amir Sabet et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Therapeutic strategies for neuroendocrine liver metastases
- (2014) Andrea Frilling et al. CANCER
- [111In-DTPA]octreotide Tumor Uptake in GEPNET Liver Metastases After Intra-Arterial Administration: An Overview of Preclinical and Clinical Observations and Implications for Tumor Radiation Dose After Peptide Radionuclide Therapy
- (2014) Stefan E. Pool et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours
- (2014) Samer Ezziddin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Predictors of Long-Term Outcome in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
- (2014) S. Ezziddin et al. JOURNAL OF NUCLEAR MEDICINE
- The Efficacy of Hepatic 90Y Resin Radioembolization for Metastatic Neuroendocrine Tumors: A Meta-Analysis
- (2014) Z. Devcic et al. JOURNAL OF NUCLEAR MEDICINE
- Recommendations for management of patients with neuroendocrine liver metastases
- (2014) Andrea Frilling et al. LANCET ONCOLOGY
- Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Patients With Somatostatin Receptor–Expressing Neuroendocrine Tumors
- (2014) Ebrahim S. Delpassand et al. PANCREAS
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
- (2013) An-Wen Chan et al. ANNALS OF INTERNAL MEDICINE
- Endocrine Tumours: Epidemiology of malignant digestive neuroendocrine tumours
- (2013) C Lepage et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Experimental designs for small randomised clinical trials: an algorithm for choice
- (2013) Catherine Cornu et al. Orphanet Journal of Rare Diseases
- Lutetium-labelled peptides for therapy of neuroendocrine tumours
- (2012) B. L. R. Kam et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 90Y Radioembolization After Radiation Exposure from Peptide Receptor Radionuclide Therapy
- (2012) S. Ezziddin et al. JOURNAL OF NUCLEAR MEDICINE
- Hepatic arterial infusion enhances DOTATOC radiopeptide therapy in patients with neuroendocrine liver metastases
- (2011) Clemens Kratochwil et al. ENDOCRINE-RELATED CANCER
- Intraindividual Comparison of Selective Arterial versus Venous 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors
- (2010) C. Kratochwil et al. CLINICAL CANCER RESEARCH
- Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters
- (2010) Martin B Niederle et al. ENDOCRINE-RELATED CANCER
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases
- (2008) Georgios S. Limouris et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastroenteropancreatic neuroendocrine tumours
- (2008) Irvin M Modlin et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now